§ 48-843.01. Short title.

Current through October 23, 2012

This chapter may be cited as the "Pharmaceutical Education Program Establishment Act of 2008".

                
                    var val = document.getElementById('citecontent').innerHTML;
                    art.dialog.defaults.title = window.location.href;
                    art.dialog.data('cite', val);
                    art.dialog.data('homeDemoPath', '/Scripts/plus/artDialog/');
                    art.dialog.open('/Scripts/plus/artDialog/citeiframe.html');

(Mar. 26, 2008, D.C. Law 17-131, § 401, 55 DCR 1659.)

HISTORICAL AND STATUTORY NOTES

Legislative History of Laws

Law 17-131, the "SafeRx Amendment Act of 2008", was introduced in Council and assigned Bill No. 17-364 which was referred to the Committee on Health. The Bill was adopted on first and second readings on December 11, 2007, and January 8, 2008, respectively. Signed by the Mayor on February 1, 2008, it was assigned Act No. 17-282 and transmitted to both Houses of Congress for its review. D.C. Law 17-131 became effective on March 26, 2008.

§ 48-843.02. Definitions.

Current through October 23, 2012 Back to Top

For the purposes of this chapter, the term "pharmaceutical product" shall have the same meaning as provided in § 3-1201.02(10A)(B)(iii).

                
                    var val = document.getElementById('citecontent').innerHTML;
                    art.dialog.defaults.title = window.location.href;
                    art.dialog.data('cite', val);
                    art.dialog.data('homeDemoPath', '/Scripts/plus/artDialog/');
                    art.dialog.open('/Scripts/plus/artDialog/citeiframe.html');

(Mar. 26, 2008, D.C. Law 17-131, § 402, 55 DCR 1659.)

HISTORICAL AND STATUTORY NOTES

Legislative History of Laws

For Law 17-131, see notes following § 48-843.01.

§ 48-843.03. Establishment of the Pharmaceutical Education Program.

Current through October 23, 2012 Back to Top

(a) There is established an evidence-based Pharmaceutical Education Program ("Program") within the Department of Health. The Program shall:

(1) Educate prescribers who participate in the District of Columbia Medicaid program, and other publicly funded, contracted, or subsidized health-care programs, on the therapeutic and cost-effective utilization of pharmaceutical products;

(2) Inform prescribers about pharmaceutical product marketing practices that are intended to circumvent competition from generic, other therapeutically-equivalent alternatives, or other evidence-based treatment options; and

(3) Utilize, or incorporate into the Program, other independent educational resources or models proven effective in promoting high-quality, evidenced-based, cost-effective information regarding the effectiveness and safety of pharmaceutical products.

(b) The Program shall be made available to prescribers who do not participate in the District of Columbia Medicaid program or other publicly funded, contracted, or subsidized health-care programs on a subscription basis.

(c) If approved by the Board of Medicine, the PE program may be used to satisfy continuing education requirements for the practice of medicine.

                
                    var val = document.getElementById('citecontent').innerHTML;
                    art.dialog.defaults.title = window.location.href;
                    art.dialog.data('cite', val);
                    art.dialog.data('homeDemoPath', '/Scripts/plus/artDialog/');
                    art.dialog.open('/Scripts/plus/artDialog/citeiframe.html');

(Mar. 26, 2008, D.C. Law 17-131, § 403, 55 DCR 1659.)

HISTORICAL AND STATUTORY NOTES

Legislative History of Laws

For Law 17-131, see notes following § 48-843.01.

§ 48-843.04. Applicability.

Current through October 23, 2012 Back to Top

This chapter shall apply upon inclusion of its fiscal effect in an approved budget and financial plan.

                
                    var val = document.getElementById('citecontent').innerHTML;
                    art.dialog.defaults.title = window.location.href;
                    art.dialog.data('cite', val);
                    art.dialog.data('homeDemoPath', '/Scripts/plus/artDialog/');
                    art.dialog.open('/Scripts/plus/artDialog/citeiframe.html');

(Mar. 26, 2008, D.C. Law 17-131, § 404, 55 DCR 1659.)

HISTORICAL AND STATUTORY NOTES

Legislative History of Laws

For Law 17-131, see notes following § 48-843.01.